Jennifer Lam - RPHM Old Principal Officer

RPHMDelisted Stock  USD 18.20  1.40  8.33%   

Insider

Jennifer Lam is Principal Officer of RPHM Old
Phone858 283 0280
Webhttps://reneopharma.com

RPHM Old Management Efficiency

The company has return on total asset (ROA) of (0.3372) % which means that it has lost $0.3372 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.54) %, meaning that it created substantial loss on money invested by shareholders. RPHM Old's management efficiency ratios could be used to measure how well RPHM Old manages its routine affairs as well as how well it operates its assets and liabilities.
RPHM Old currently holds 973 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. RPHM Old has a current ratio of 15.52, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about RPHM Old's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Niamh AlixPrime Medicine, Common
N/A
Marni KottleKronos Bio
N/A
Tycho PetersonAdaptive Biotechnologies Corp
50
MBA MDImmix Biopharma
49
Andrew HirschC4 Therapeutics
53
Vicky HahneCelcuity LLC
58
Mark DmytrukGinkgo Bioworks Holdings
54
Nadir MahmoodNkarta Inc
46
Daniel HicklinWerewolf Therapeutics
61
BCh BMKronos Bio
40
Ying HuangLegend Biotech Corp
52
Bartholomew CantonGinkgo Bioworks Holdings
N/A
Ankur DhingraSummit Therapeutics PLC
47
BSc BScHepion Pharmaceuticals
66
Lance LaingCelcuity LLC
63
DSc MSEImmix Biopharma
75
MBA JDApellis Pharmaceuticals
52
Cynthia SeidelDuganWerewolf Therapeutics
65
CPA CTPCns Pharmaceuticals
44
Reid LeonardWerewolf Therapeutics
65
Kyle PiskelAdaptive Biotechnologies Corp
41
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company was incorporated in 2014 and is headquartered in Irvine, California. Reneo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people. RPHM Old (RPHM) is traded on NASDAQ Exchange in USA and employs 8 people.

Management Performance

RPHM Old Leadership Team

Elected by the shareholders, the RPHM Old's board of directors comprises two types of representatives: RPHM Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RPHM. The board's role is to monitor RPHM Old's management team and ensure that shareholders' interests are well served. RPHM Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RPHM Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gregory Flesher, CEO President
Alejandro MD, Chief Officer
Ashley JD, Chief Officer
Wendy MBA, Consultant
Vineet Jindal, Consultant
Michael Cruse, Chief Officer
Jennifer Lam, Principal Officer
Lynn Purkins, Senior Development
Michael Grey, Founder Chairman

RPHM Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is RPHM Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in RPHM Stock

If you are still planning to invest in RPHM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RPHM Old's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes